Breaking News Instant updates and real-time market news.

ULTA

Ulta Beauty

$334.29

0.14 (0.04%)

, AMZN

Amazon.com

$1,775.60

13.15 (0.75%)

12:47
03/20/19
03/20
12:47
03/20/19
12:47

Amazon risk still manageable for beauty retailers, says Jefferies

Jefferies analyst Stephanie Wissink said Amazon's (AMZN) launch of a value priced private label skincare brand, Belei, "came as a bit of a surprise," adding that her sense from contacts inside and outside of the e-commerce company is that the launch is meant to establish a stronger presence, refine a more robust beauty platform and provide data to improve access to national brands. Wissink said it has become increasingly competitive for smaller brands to get into Sephora and Ulta (ULTA) and she expects Amazon to gain access to a growing number of small brands. Wissink points to Ulta's recent strong report as an indicator that with the right, curated assortment, the company is able to protect its position and gain share. Publicly traded skincare and beauty product makers include Estee Lauder (EL), Revlon (REV), Coty (COTY) and e.l.f. Beauty (ELF).

ULTA

Ulta Beauty

$334.29

0.14 (0.04%)

AMZN

Amazon.com

$1,775.60

13.15 (0.75%)

ELF

e.l.f. Beauty

$9.73

0.495 (5.36%)

REV

Revlon

$19.49

1.47 (8.16%)

EL

Estee Lauder

$158.67

-2.03 (-1.26%)

COTY

Coty

$11.42

-0.08 (-0.70%)

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

  • 01

    May

ULTA Ulta Beauty
$334.29

0.14 (0.04%)

03/15/19
BARD
03/15/19
NO CHANGE
BARD
Baird remains a buyer of Ulta Beauty after Q4 results
Baird analyst Mark Altschwager maintained an Outperform rating on Ulta Beauty and raised his price target to $365 from $325 following the company's Q4 earnings release. The analyst noted that FY19 guidance straddled the consensus, and said "the quarter demonstrated the virtues and durability of Ulta's best-in-class omnichannel model and provided greater confidence in the growth trajectory ahead".
03/18/19
LOOP
03/18/19
NO CHANGE
Target $340
LOOP
Hold
Ulta Beauty price target raised to $340 from $315 at Loop Capital
Loop Capital analyst Anthony Chukumba raised his price target on Ulta Beauty to $340 to reflect the findings of his latest prestige beauty product pricing study that suggests retailers "continue to largely adhere to manufacturer's suggested retail prices, with discounting still virtually non-existent." The analyst sees the pricing trends as a positive for Ulta Beauty given its "wider assortment of prestige and mass market brands" relative to the competition, along with its "robust" loyalty program and many cases of exclusive brand relationships. Chukumba adds that the decline in "free gift with purchase" offers suggests "strengthening prestige beauty products demand", but also keeps his Hold rating on the shares given Ulta Beauty's valuation.
03/15/19
JEFF
03/15/19
NO CHANGE
Target $357
JEFF
Buy
Ulta Beauty price target raised to $357 from $335 at Jefferies
Jefferies analyst Stephanie Wissink raised her price target for Ulta Beauty to $357 from $335 saying the company's Q4 sales and earnings beats "were needed" and "validated a defensibility belief that was getting lost in the quarterly comp vs margin debate." The company's growth sustainability supports a higher multiple, Wissink tells investors in a post-earnings research note. She keeps a Buy rating on Ulta Beauty.
03/15/19
BMOC
03/15/19
NO CHANGE
Target $325
BMOC
Market Perform
Ulta Beauty price target raised to $325 from $280 at BMO Capital
BMO Capital analyst Shannon Coyne raised her price target on Ulta Beauty to $325 after its Q4 earnings beat, better than expected sales growth, and gross margin expansion. The analyst notes that she is more confident about re-acceleration in the company's comps as its growth initiatives - "loyalty, focus on digitally native brands, salon" - take hold. Longer term, Coyne is keeping her Market Perform rating however and anticipates "clouds on the horizon" in the overall Beauty Channel Distribution sector, suggesting that Ulta Beauty will "need to continue to increase investments in digital to drive growth."
AMZN Amazon.com
$1,775.60

13.15 (0.75%)

03/15/19
KEYB
03/15/19
UPGRADE
Target $2100
KEYB
Overweight
KeyBanc upgrades Amazon to Overweight on improving retail profitability
KeyBanc analyst Edward Yruma upgraded Amazon.com to Overweight from Sector Weight with a price target of $2,100. The stock in premarket trading is up $22.78 to $1,709.00. Amazon is taking a number of operational moves to improve profitability in core retail, which could drive mid-term earnings above current consensus estimates, Yruma tells investors in a research note. He believes Amazon is "pivoting to a company with accelerating profitability." And in addition to $5B in incremental retail profitability, growth and margins remain "very strong" in the combined Web Services and advertising businesses, says the analyst. Amazon's profits over the next three years could inflect, driven by improving retail margin expansion coupled with the mix shift to higher margin AWS and Advertising segments that combined could top $100B by 2022, Yruma contends.
03/15/19
03/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Amazon.com (AMZN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Edward Yruma saying Amazon is taking a number of operational moves to improve profitability in core retail, which could drive mid-term earnings above current consensus estimates. 2. AT&T (T) upgraded to Outperform from Market Perform at Raymond James with analyst Frank Louthan saying AT&T shares trade at a relative discount and expects shares to be driven by positive earnings growth combined with a strong de-levering story. 3. Colfax (CFX) upgraded to Equal Weight from Underweight at Barclays with analyst Julian Mitchell saying he views the company's turnaround story as underappreciated. 4. Rent-A-Center (RCII) upgraded to Outperform from Market Perform at Raymond James with analyst Budd Bugatch citing the trial win regarding the terminated buyout with Vintage Capital and a strong fundamental outlook for the upgrade. 5. Global Net Lease (GNL) upgraded to Buy from Neutral at B. Riley FBR with analyst Bryan Maher citing the stock's attractive relative valuation as well as management's acquisition "acumen" for the upgrade to Buy. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/19
KEYB
03/20/19
NO CHANGE
KEYB
Google's Stadia announcement potentially disruptive, says KeyBanc
KeyBanc analyst Evan Wingren attended Google's (GOOG; GOOGL) keynote at Game Developer's Conference, where it announced a new video game streaming service, new gaming hardware, and intentions to make games. The analyst believes the announcement has potential to be disruptive if Google executes well on the service, and sees it as mostly positive for video game publishers in the near and long term as it increases global access, removes value added by hardware, and increases value of key content. Google's ambitions to make games join other distributors like Sony (SNE), Microsoft (MSFT), and Amazon (AMZN), and could provide some incremental competition for time in the medium to long term, Wingren contends.
03/20/19
EVER
03/20/19
INITIATION
Target $1965
EVER
Outperform
Amazon.com initiated with an Outperform at Evercore ISI
Evercore ISI analyst Greg Melich initiated co-coverage of Amazon.com with the firm's Internet Team, led by Anthony DiClemente. They have an Outperform rating and $1,965 base case price target on the stock, citing the view that the company will continue to change "the way we shop and live." While the company's percentage growth might slow, its dollar growth and profitability are improving, Melich noted.
ELF e.l.f. Beauty
$9.73

0.495 (5.36%)

03/12/19
DADA
03/12/19
NO CHANGE
Target $7
DADA
Neutral
e.l.f. Beauty price target lowered to $7 from $9.25 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on e.l.f. Beauty to $7 and kept her Neutral rating, also lowering her FY20 EBITDA outlook to $55M from $69M after its disappointing most recent quarter reported last month. The analyst is positive on the company's brand support investment and its search for a new CFO, but warns that the probability of it being bought is reduced the longer its sales decline continues. Weiser intends to remain at neutral until she sees improved "top-line growth visibility through better category and market share performance."
03/05/19
JEFF
03/05/19
NO CHANGE
JEFF
Hold
Revlon sales declines reported to worsen in February, says Jefferies
After reviewing Nielsen data through Feb. 23, Jefferies Stephanie Wissink noted that mass beauty sales decelerated to down 4% in the trailing 4 week period, with all categories stepping lower. By brand, Revlon sales decline of 15% was a deceleration, L'Oreal's (LRCLY) 2% decline was a slight deceleration, e.l.f. Beauty's (ELF) decline of 3% was stable and Coty's (COTY) 4% decline was improved, Wissink tells investors. She keeps Hold rating on all four mass beauty product makers mentioned. In morning trading, shares of Revlon are down $4.95. or 19.4%, to $20.62.
02/27/19
BMOC
02/27/19
NO CHANGE
Target $7
BMOC
Market Perform
e.l.f. Beauty price target lowered to $7 from $14 at BMO Capital
BMO Capital analyst Shannon Coyne lowered her price target on e.l.f. Beauty to $7 and kept her Market Perform rating after its Q4 revenue miss, saying the company will continue to face weakness amid intensifying competitive environment. With a lack of earnings visibility, the analyst also expects the company to close its unprofitable stores and focus marketing spending on digital and national retailers, adding that she is also concerned with execution risks related to the recently announced packaging initiative called Project Unicorn.
01/28/19
DADA
01/28/19
NO CHANGE
Target $9.25
DADA
Neutral
e.l.f. Beauty price target lowered to $9.25 from $13.50 at DA Davidson
DA Davidson analyst Linda Bolton Weiser lowered her price target on e.l.f. Beauty to $9.25 and kept her Neutral rating after the latest letter sent by activist investor Marathon Partners. Unlike the first letter, which urged the board to put the company up for sale, the analyst notes that the latest letter focused on cost reduction, including executive compensation. The analyst adds that while e.l.f Beauty looks lie a "very profitable company", a closer examination reveals its elevated cost structure and relatively low profitability, further noting that the visibility on its revenue growth remains limited.
REV Revlon
$19.49

1.47 (8.16%)

03/05/19
JEFF
03/05/19
NO CHANGE
JEFF
Nielsen data shows worsening trends for Revlon, says Jefferies
EL Estee Lauder
$158.67

-2.03 (-1.26%)

03/07/19
JPMS
03/07/19
UPGRADE
Target $175
JPMS
Overweight
JPMorgan upgrades Estee Lauder to Overweight, boosts target to $175
JPMorgan analyst Andrea Teixeira upgraded Estee Lauder to Overweight from Neutral and raised her price target for the shares to $175 from $160. The analyst left the company's analyst day more confident that both its fiscal 2019 and long term sales growth algorithm and earnings goals are "not only achievable but actually conservative." Estee is seeing continued strength in China despite difficult compares and has "ample runway" for further expansion ahead in Emerging Markets and travel, Teixeira tells investors in a research note. Further, innovation for Clinique should sustain double digits skincare growth in the developed markets and mitigate low-single-digit growth in makeup, adds the analyst. She believes concerns over Estee Lauder's growth deceleration are overdone.
03/07/19
RBCM
03/07/19
NO CHANGE
Target $173
RBCM
Outperform
Estee Lauder price target raised to $173 from $168 at RBC Capital
RBC Capital analyst Nik Modi raised his price target on Estee Lauder to $173 and kept his Outperform rating after its Analyst Day. The analyst sees the company's Leading Beauty Forward cost saving initiative "ramping nicely", allowing for its investment in brand spending, promotional activities, and digital marketing. Modi is also positive on Estee Lauder management striking the "right balance between margin expansion and top line" growth.
03/07/19
DADA
03/07/19
NO CHANGE
Target $179
DADA
Buy
Estee Lauder top line growth target may be conservative, says DA Davidson
DA Davidson analyst Linda Bolton Weiser kept her Buy rating and $179 price target on Estee Lauder after its Analyst Day meeting, saying that barring a recession, the company's long-term revenue growth target of 6%-8% may be conservative. The analyst cites Estee Lauder's "substantial growth opportunity in travel retail", outlook for prestige beauty market growth in China / emerging markets, and the majority of North American sales coming in the company's fast-growing channels.
03/07/19
03/07/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Abercrombie & Fitch (ANF) upgraded to Neutral from Underweight at JPMorgan with analyst Matthew Boss saying the company's Q4 beat shows it is executing in a "tough tape." 2. Estee Lauder (EL) upgraded to Overweight from Neutral at JPMorgan with analyst Andrea Teixeira saying she left the company's analyst day more confident that both its fiscal 2019 and long term sales growth algorithm and earnings goals are "not only achievable but actually conservative." 3. Baytex Energy (BTE) upgraded to Outperform from Neutral at Macquarie. 4. Armstrong Flooring (AFI) upgraded to Hold from Sell at Zelman. 5. World Fuel Services (INT) upgraded to Buy from Neutral at Seaport Global with analyst Kevin Sterling saying management is "culling low-margin" businesses as it focuses on profitability above volume growth and market share gains. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COTY Coty
$11.42

-0.08 (-0.70%)

11/15/18
11/15/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Mylan (MYL) upgraded to Buy from Hold at Argus with analyst Jasper Hellweg saying the stock appears to be close to an inflection after several quarters of underperformance. 2. CopyTele (COPY) upgraded to Outperform from Market Perform at BMO Capital. 3. Voyager Therapeutics (VYGR) upgraded to Strong Buy from Outperform at Raymond James. 4. Athenex (ATNX) upgraded to Overweight from Neutral at JPMorgan with analyst Leon Chik saying more clinical data and progress in new drug trials should boost investor sentiment in 2019. 5. Coty (COTY) upgraded to Outperform from Market Perform at BMO Capital with analyst Shannon Coyne saying that her downgrade in August was driven by concerns around the company's supply chain issues, but believes that these factors have now been fully priced in after the management withdrew its guidance and consensus earnings have been pulled back by about 30%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/11/19
JPMS
02/11/19
NO CHANGE
Target $10
JPMS
Neutral
Coty price target raised to $10 from $7 at JPMorgan
JPMorgan analyst Andrea Teixeira raised her price target for Coty to $10 following the company's Q2 beat and keeps a Neutral rating on the shares. The analyst found "renewed energy from new management encouraging," but points out there there were "no major financial strings or timing attached to the turnaround at this point." Teixeira sees "massive execution risks" for the company, which keeps her on the sidelines post Friday's 32% "relief rally."
01/04/19
JPMS
01/04/19
UPGRADE
Target $7
JPMS
Neutral
Coty upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Andrea Teixeira upgraded Coty to Neutral with a $7 price target. The analyst's sum-of-the-parts analysis indicates Coty's valuation is "flushed out" at current levels. Teixeira, however, still sees potential downside to consensus estimates.

TODAY'S FREE FLY STORIES

WFC

Wells Fargo

$53.80

0.3 (0.56%)

, AAPL

Apple

$265.73

3.07 (1.17%)

10:01
11/16/19
11/16
10:01
11/16/19
10:01
Periodicals
Berkshire Hathaway inactive with record cash hoard, Barron's says »

Berkshire Hathaway…

WFC

Wells Fargo

$53.80

0.3 (0.56%)

AAPL

Apple

$265.73

3.07 (1.17%)

OXY

Occidental Petroleum

$38.94

1.18 (3.13%)

BRK.B

Berkshire Hathaway

$219.74

0.38 (0.17%)

BRK.A

Berkshire Hathaway

$329,361.11

266.11 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

DIS

Disney

$144.63

-2.56 (-1.74%)

09:43
11/16/19
11/16
09:43
11/16/19
09:43
Periodicals
Disney+ may not be able to hold onto huge number of subs, Barron's says »

While Disney's (DIS)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$112.11

2.9 (2.66%)

09:27
11/16/19
11/16
09:27
11/16/19
09:27
Periodicals
Medtronic shares 'could rise even more,' Barron's says »

Barron's recommended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BR

Broadridge

$119.80

0.485 (0.41%)

09:18
11/16/19
11/16
09:18
11/16/19
09:18
Periodicals
Broadridge a defensive name that can withstand slowdown, Barron's says »

Broadridge Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCD

McDonald's

$193.95

-0.02 (-0.01%)

, MDT

Medtronic

$112.11

2.9 (2.66%)

09:07
11/16/19
11/16
09:07
11/16/19
09:07
Periodicals
Barron's suggests dividend stocks for retirement savers »

In this week's…

MCD

McDonald's

$193.95

-0.02 (-0.01%)

MDT

Medtronic

$112.11

2.9 (2.66%)

KO

Coca-Cola

$52.67

0.03 (0.06%)

PRU

Prudential

$93.61

0.82 (0.88%)

SYF

Synchrony

$37.05

0.34 (0.93%)

KEY

KeyCorp

$18.96

0.1 (0.53%)

T

AT&T

$39.49

0.53 (1.36%)

AMGN

Amgen

$220.84

2.29 (1.05%)

CSCO

Cisco

$45.10

0.18 (0.40%)

RCL

Royal Caribbean

$117.91

2.69 (2.33%)

MRK

Merck

$84.89

0.33 (0.39%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

JPM

JPMorgan

$129.51

0.83 (0.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 18

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 22

    Nov

  • 02

    Dec

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 10

    Dec

  • 10

    Dec

  • 14

    Jan

  • 21

    Jan

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 29

    Jan

  • 05

    Feb

  • 12

    Feb

  • 14

    Mar

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

, MSFT

Microsoft

$149.95

1.89 (1.28%)

08:54
11/16/19
11/16
08:54
11/16/19
08:54
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,737.49

-17.22 (-0.98%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

AAPL

Apple

$265.73

3.07 (1.17%)

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

THC

Tenet

$30.55

1.08 (3.66%)

GM

General Motors

$36.87

0.07 (0.19%)

FCAU

Fiat Chrysler

$16.02

0.04 (0.25%)

TM

Toyota

$144.29

1.16 (0.81%)

F

Ford

$8.96

0.16 (1.82%)

HMC

Honda

$28.99

0.155 (0.54%)

VWAGY

Volkswagen

$0.00

(0.00%)

BMWYY

BMW

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 04

    Feb

  • 06

    Feb

MDCO

The Medicines Co.

$51.92

1.03 (2.02%)

04:55
11/16/19
11/16
04:55
11/16/19
04:55
Conference/Events
Roth Capital pharmaceuticals analysts to hold a luncheon »

Analysts host Dr. John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

CVET

Covetrus

$14.93

1.44 (10.67%)

18:41
11/15/19
11/15
18:41
11/15/19
18:41
Hot Stocks
Covetrus CEO: We're a leader in the humanization of pets »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.54

-0.93 (-2.05%)

18:02
11/15/19
11/15
18:02
11/15/19
18:02
Hot Stocks
Viacom extends cable deal for 'The Office' through 2025 »

Viacom (VIA) announced…

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.54

-0.93 (-2.05%)

VIAB

Viacom

$23.07

0.59 (2.62%)

VIA

Viacom

$26.59

1.28 (5.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

CWK

Cushman & Wakefield

$19.10

0.1 (0.53%)

17:48
11/15/19
11/15
17:48
11/15/19
17:48
Hot Stocks
Cushman & Wakefield CEO sells 84.6K share of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

LMT

Lockheed Martin

$393.52

3.305 (0.85%)

17:39
11/15/19
11/15
17:39
11/15/19
17:39
Hot Stocks
Lockheed Martin awarded maximum $3.33B Air Force contract »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESCA

Escalade

$10.90

-0.09 (-0.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Escalade CEO Fetherman to retire »

Escalade announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$12.96

0.1 (0.78%)

, ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

17:38
11/15/19
11/15
17:38
11/15/19
17:38
Hot Stocks
Eldorado, Caesars stockholders approve Eldorado acquisition of Caesars »

Eldorado Resorts (ERI)…

CZR

Caesars

$12.96

0.1 (0.78%)

ERI

Eldorado Resorts

$52.10

0.93 (1.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EGRX

Eagle Pharmaceuticals

$57.24

0.55 (0.97%)

17:15
11/15/19
11/15
17:15
11/15/19
17:15
Syndicate
Breaking Syndicate news story on Eagle Pharmaceuticals »

Eagle Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FN

Fabrinet

$60.82

0.84 (1.40%)

17:11
11/15/19
11/15
17:11
11/15/19
17:11
Hot Stocks
Fabrinet President Gill sells 12.9K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

TEUM

Pareteum

$0.38

-0.0209 (-5.21%)

17:05
11/15/19
11/15
17:05
11/15/19
17:05
Hot Stocks
Pareteum receives noncompliance notice from Nasdaq »

Pareteum announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

Hexo

$1.78

-0.1 (-5.32%)

17:00
11/15/19
11/15
17:00
11/15/19
17:00
Hot Stocks
Hexo was cannabis was being grown in unlicensed space at Niagara site »

HEXO Corp provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$220.84

2.29 (1.05%)

, CELG

Celgene

$110.02

-0.01 (-0.01%)

16:57
11/15/19
11/15
16:57
11/15/19
16:57
Hot Stocks
Bristol-Myers gets FTC clearance for Celgene acquisition »

Bristol-Myers Squibb…

AMGN

Amgen

$220.84

2.29 (1.05%)

CELG

Celgene

$110.02

-0.01 (-0.01%)

BMY

Bristol-Myers

$58.61

0.11 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 04

    Dec

  • 07

    Dec

  • 25

    Mar

  • 04

    Apr

RAVE

Rave Restaurant

$1.44

-0.79 (-35.43%)

16:47
11/15/19
11/15
16:47
11/15/19
16:47
Hot Stocks
BBRC Asset Management reports 6.6% passive stake in Rave Restaurant »

BBRC Asset Management …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHAP

Chaparral Energy

$0.89

-0.0521 (-5.52%)

16:46
11/15/19
11/15
16:46
11/15/19
16:46
Hot Stocks
Chaparral Energy receives continued listing standard notice from NYSE »

Chaparral Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

16:45
11/15/19
11/15
16:45
11/15/19
16:45
General news
Breaking General news story  »

San Francisco Federal…

CI

Cigna

$196.08

6.41 (3.38%)

, CNC

Centene

$57.57

2.91 (5.32%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
On The Fly
Fly Intel: Wall Street's top stories for Friday »

Stocks closed out the…

CI

Cigna

$196.08

6.41 (3.38%)

CNC

Centene

$57.57

2.91 (5.32%)

CVS

CVS Health

$74.27

1.34 (1.84%)

HUM

Humana

$335.43

17.48 (5.50%)

UNH

UnitedHealth

$269.44

13.68 (5.35%)

WCG

WellCare

$312.01

10.155 (3.36%)

HNT

Health Net

$0.00

(0.00%)

MOH

Molina Healthcare

$129.60

7.3 (5.97%)

ANTM

Anthem

$298.18

16.14 (5.72%)

HCA

HCA Healthcare

$137.98

3.51 (2.61%)

CYH

Community Health

$3.12

0.25 (8.71%)

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$144.30

3.13 (2.22%)

NVDA

Nvidia

$204.12

-5.76 (-2.74%)

AMZN

Amazon.com

$1,739.33

-15.38 (-0.88%)

MSFT

Microsoft

$149.95

1.89 (1.28%)

UAA

Under Armour

$17.78

0.65 (3.79%)

UA

Under Armour

$15.97

0.41 (2.64%)

AMRN

Amarin

$23.99

2.5 (11.63%)

JNJ

Johnson & Johnson

$134.97

3.99 (3.05%)

GOOG

Alphabet

$1,334.01

21.82 (1.66%)

GOOGL

Alphabet Class A

$1,333.33

23.54 (1.80%)

ORCL

Oracle

$56.43

0.33 (0.59%)

RH

RH

$188.73

13.535 (7.73%)

QGEN

Qiagen

$40.56

3.255 (8.73%)

FTCH

Farfetch

$9.66

2.17 (28.97%)

THC

Tenet

$30.55

1.08 (3.66%)

TORC

resTORbio

$1.10

-6.83 (-86.13%)

ACB

Aurora Cannabis

$2.72

-0.57 (-17.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 20

    Nov

  • 22

    Nov

  • 04

    Dec

  • 07

    Dec

  • 09

    Dec

  • 09

    Dec

  • 13

    Dec

  • 28

    Dec

  • 06

    Jan

  • 21

    Jan

  • 06

    Feb

NYT

New York Times

$31.60

0.44 (1.41%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
New York Times CEO sells 66,000 class A common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

WEX

Wex

$200.52

4.61 (2.35%)

16:41
11/15/19
11/15
16:41
11/15/19
16:41
Hot Stocks
Wex director Morris sells 3K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.